Clinical Trial Update: Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of TAS-102 tablets versus an oral solution containing equivalent amounts of trifluridine and tipiracil; study completed in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Solid Tumors (Excluding Breast Cancer) | Phase 1 | Status: COMPLETED